Fondaparinux reduces all types of symptomatic thromboembolic complications in patients with superficial-vein thrombosis in the legs: data from the CALISTO study - Leizorovicz, A; Prandoni, P; Decousus, H; on behalf of the Steering Committee of the CALISTO Study (Blood, 2011)